• Home
  • Services
  • IP Value Blog
  • FAQ
  • About Us
  • Contact

VLF Consulting, Inc.

  • ARTICLES

    December 17, 2011 Entire Market Value Rule, License Agreement Comparability

    CA Court Weighs in on License Agreement Comparability, EMV Rule

    In a ruling on post-trial motions in Broadcom v. Emulex, the Central District of California clarified its requirements on what it takes for a license agreement to be “comparable” and the importance of the “smallest saleable unit” and other licenses when determining the royalty base. The court first considers Defendant’s claim that Plaintiff relied upon a license agreement without sufficiently proving comparability.  The court finds that although the technologies are not similar, they are sufficiently comparable because they are contained in modules installed on the same chips then used in other products, and because the technologies/agreements were sufficiently explained to the jury.  For example, the jury heard testimony that the license was comparable in contribution to the performance of the overall product at issue (the chip) as well as testimony about the running royalty / lump sum terms.  The court also distinguishes the license at issue here from the licenses rejected by the Lucent and ResQNet courts. The court then reviews Defendant’s claim that the royalty base should not be the chips, but rather the smaller cores (which directly included the patented technology).  The court focuses its ruling on what was the smallest saleable unit.  The Plaintiff says the chip was the ... Read More
    December 14, 2011 Apportionment Techniques, License Agreement Comparability

    ResQNet on Remand: Court Rejects Expert Opinions and Sets a Royalty Rate

    Recall that the Federal Circuit remanded this case for a recalculation of a reasonable royalty, finding that the plaintiff’s expert and the lower court impermissibly relied upon broader re-branding and re-bundling licenses that furnished finished software products, source code, and other services.  Upon remand, the court rejects revised opinions by both plaintiff’s and defendant’s experts and assesses a 3% royalty rate. After excluding the re-branding/re-bundling agreements that called for 25% to 40% royalties, both experts (Dr. Jesse David for ResQNet and Brian Blonder for Lansa) focused on two remaining agreements, one being a settlement.  Note, too, that the Federal Circuit had hinted that one of the “straight” licenses called for royalties of roughly 1.5 to 2%; see ResQNet.com, Inc. v. Lansa, Inc., 594 F.3d 860, 868 (Fed. Cir. 2010).  The court endorses Dr. David’s scaling up of the royalty to account for a difference in the royalty base, but the court finds that he did not adequately apportion the rate to account for the multiple patents covered.  It thus rejects his royalty opinion of 8% to 10% (down from his prior opinion of 12.5%). Meanwhile, Mr. Blonder divided the royalty rate by the number of patents covered, to arrive at a royalty ... Read More
    December 10, 2011 Apportionment Techniques, Entire Market Value Rule

    Oracle v. Google: Strike Two for Oracle’s Damages Positions

    We at IP Value Blog have been following the damages arguments in this case, about which the court has expressed some firm opinions.  In July, the court excluded the opinions by Oracle’s expert Dr. Cockburn for several reasons, including a failure to apportion the demand for Google’s Android with respect to plaintiff’s Java platform and specifically the asserted claims.  The court at that time gave suggestions on how Oracle should structure its revised damages opinions.  After reviewing the revised opinions, the court now strikes Dr. Cockburn’s opinions on apportionment and a large portion of his second report. As the court suggested in July, Dr. Cockburn started his assessment of a reasonable royalty with the $100 million licensing offer by plaintiff Sun, then apportioned this downward.  For the apportionment, Dr. Cockburn analyzed the value of the claimed features with respect to the Android platform, but the court faults him for not analyzing the value of the claimed features with respect to the other components of value that made up the licensing offer that the parties were considering (citing a 2002 Medtronic case: Medtronic, Inc. v. Boston Scientific Corp., 2002 WL 34447587 at *12, D. Minn. Aug. 8 2002). The court also faults Dr. ... Read More
    December 5, 2011 Entire Market Value Rule

    Judge Declines to Order Plaintiff to Detail EMVR Strategy in ROG Response

    Due to the dramatic impact that the Entire Market Value Rule can have on the amount of damages (by expanding the royalty base), it stands to reason that defendants would want to know as early as possible if plaintiff will attempt to apply the EMVR rule to use a larger royalty base.  This California court considered a motion by defendant HP to compel plaintiff to provide more definite responses regarding its possible use of the EMVR.  HP could then presumably tailor its fact discovery and focus its expert's work accordingly.  The plaintiff’s position, not surprisingly, was that it was a matter for expert discovery, not fact discovery, and that it will be disclosed later in its expert reports.  The court sided with plaintiffs, noting that HP “does not identify or specify in any real manner exactly why the discovery which it seeks must be received before the close of fact discovery.” As a general proposition, the courts seem increasingly inclined to help the parties arrive at a general understanding of the damages issues as early as possible, as evidenced by Judge Rader’s recent comments to that effect.  This might suggest that had HP been more specific about how the EMVR issues ... Read More
    November 18, 2011 Entire Market Value Rule, License Agreement Comparability, Lump Sum, Nash Equilibrium

    On Remand, Lucent v. Microsoft Judge Slashes Jury’s Damages

    Following the jury’s $70 million lump-sum royalty damages verdict from July, the district court judge slashes Lucent’s award to $26 million, finding several shortcomings in Lucent’s damages position that the jury had accepted.  This case deals with Lucent’s Day patent, called the “date picker” patent since it allows users to schedule appointments by clicking on the Outlook calendar. First, the judge found that Lucent failed to properly apportion the value of the Day patent.  Lucent’s damages expert, Ray Sims, attempted to calculate the profits attributed to the Day patent by multiplying the total Outlook licenses by the percent of users who use the feature (43%) times the percent of users who would not buy Outlook without the feature (7%), arriving at 3%, which leads to 3.3 million license sales.  Using the full value of Outlook of $67 and a 76% profitability, this translates to an “expected foregone profit” of $139 million.  The judge had previously warned Lucent about using the full $67 value, since Lucent could not show that the Day patent was the basis for consumer demand.  The court had stated that “use as a proxy for value does not appropriately account for all the other unpatented features” and that ... Read More

    « Older
    Newer »
  • SEARCH

    What we do

    IP Value Blog focuses on news and current court cases regarding intellectual property valuation. IP Value Blog is published by Eric Phillips of VLF Consulting.

    Subscribe via Email

    TAGS

    25% Rule, Apportionment Techniques, Data Considered, Date of Hypothetical Negotiation, Daubert, Entire Market Value Rule, Forward Citation Analysis, Hypothetical Negotiation, Jury Verdict Form, License Agreement Comparability, Lost Profits, Lump Sum, Method Claims, Nash Equilibrium, Non-Infringing Alternatives, Patent Reform Act, Post-Judgment Royalty, Prejudgment Interest, Royalty Base, Royalty Rate, Surveys, Use of Settlement Agreements
  • LinkedIn
© VLF Consulting, Inc. 2025
  • Privacy Policy